Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.530
-0.090 (-3.44%)
At close: Nov 20, 2024, 4:00 PM
2.570
+0.040 (1.58%)
After-hours: Nov 20, 2024, 7:00 PM EST
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $129.37 million as of November 21, 2024. Its market cap has increased by 165.64% in one year.
Market Cap
129.37M
Enterprise Value
73.39M
1-Year Change
165.64%
Ranking
Category
Stock Price
$2.53
Market Cap Chart
Since June 20, 2007, Cardiff Oncology's market cap has decreased from $1.11B to $129.37M, a decrease of -88.34%. That is a compound annual growth rate of -11.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 129.40M | 95.76% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 166.40% |
| Dec 30, 2011 | 36.90M | 5.73% |
| Dec 31, 2010 | 34.90M | -93.61% |
| Dec 31, 2008 | 546.30M | -50.74% |
| Dec 31, 2007 | 1.11B | - |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 134.50M |
| Zentek | 132.60M |
| Inhibikase Therapeutics | 132.37M |
| Cabaletta Bio | 131.97M |
| Avalo Therapeutics | 129.32M |
| Innate Pharma | 128.52M |
| Candel Therapeutics | 128.44M |
| Compugen | 128.04M |